{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T08:17:30Z","timestamp":1788509850236,"version":"build-2803163510"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Egypt Natl Canc Inst"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Colorectal carcinoma is among the most prevalent malignancies worldwide. PD-L1 is an immune-checkpoint ligand that can contribute to tumor immune evasion whereas BCL2 is an anti-apoptotic protein involved in cell-survival pathways, with its mutation frequently observed in various human cancers. This study aimed to evaluate the prognostic significance of immunohistochemically identified PD-L1 and BCL2 proteins in colorectal carcinoma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials<\/jats:title>\n                    <jats:p>Sixty paraffin-embedded colorectal carcinoma tissue specimens were subjected to immunohistochemistry (IHC) staining for PD-L1 and BCL2 expression, which was analyzed using the DAKO scoring system (0: 0\u20134%, 1: 5\u201324%, 2: 25\u201349%, 3: 50\u201374%, 4: 75\u2013100%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Result<\/jats:title>\n                    <jats:p>PD-L1 protein expression was detected in all patients, with immunoreactivity noted in 33.3% (score 3), 31.7% (score 2), 20.0% (score 4), and 15.0% (score 1), with score 0 cases showing no detectable immunoreactivity Similarly, Bcl-2 protein expression was identified in all colorectal carcinoma patients, with immunoreactivity observed in 38.3% (score 3), 25.0% (score 2), 20.0% (score 4), and 16.7% (score 1), while no detectable immunoreactivity was seen in score 0 cases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These findings highlight the ubiquitous expression of PD-L1 and Bcl-2 in colorectal carcinoma and their potential role as prognostic biomarkers, providing insights into their relevance in cancer progression and therapeutic response.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s43046-026-00409-z","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T08:10:37Z","timestamp":1788509437000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of Programmed Death Ligand-1 (PD-L1) and B-cell Lymphoma 2 (BCL2) protein expression using immunohistochemistry in colorectal carcinoma patients from Anbar Governorate"],"prefix":"10.1186","volume":"38","author":[{"given":"Akram","family":"Baraa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hekmat","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Abed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,4]]},"reference":[{"issue":"1","key":"409_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7\u201333. https:\/\/doi.org\/10.3322\/caac.21708.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"409_CR2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov. 2022;12(1):31\u201346. https:\/\/doi.org\/10.1158\/2159-8290.CD-21-1059.","journal-title":"Cancer Discov"},{"key":"409_CR3","doi-asserted-by":"publisher","first-page":"284","DOI":"10.58490\/ctjump.2026i98.4609","volume":"98","author":"TCB Nguyen","year":"2026","unstructured":"Nguyen TCB, Nguyen HP. PD-L1 expression and its correlation with histopathological characteristics in colorectal adenocarcinoma. Can Tho J Med Pharm. 2026;98:284\u201390. https:\/\/doi.org\/10.58490\/ctjump.2026i98.4609.","journal-title":"Can Tho J Med Pharm"},{"issue":"5","key":"409_CR4","doi-asserted-by":"publisher","first-page":"4125","DOI":"10.3892\/etm.2017.5100","volume":"14","author":"J Tao","year":"2017","unstructured":"Tao J, Dai J, Hou S. Association between B7-H1 and cervical cancer: B7-H1 impairs the immune response in human cervical cancer cells. Exp Ther Med. 2017;14(5):4125\u201333. https:\/\/doi.org\/10.3892\/etm.2017.5100.","journal-title":"Exp Ther Med"},{"key":"409_CR5","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.3389\/fonc.2019.01276","volume":"9","author":"Z Mei","year":"2020","unstructured":"Mei Z, Liang M, Li L, Zhang Y, Wang Q, Yang W, et al. PD-L1 expression and prognosis in colorectal cancer: A meta-analysis. Front Oncol. 2020;9:1276. https:\/\/doi.org\/10.3389\/fonc.2019.01276.","journal-title":"Front Oncol"},{"issue":"6","key":"409_CR6","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1158\/0008-5472.can-15-3175","volume":"76","author":"R Mandal","year":"2016","unstructured":"Mandal R, Chan TA, Sadelain M. Mechanisms of immune evasion in colorectal cancer. Cancer Res. 2016;76(6):1362\u201370. https:\/\/doi.org\/10.1158\/0008-5472.can-15-3175.","journal-title":"Cancer Res"},{"issue":"1","key":"409_CR7","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1158\/2159-8290.cd-14-0863","volume":"5","author":"NJ Llosa","year":"2015","unstructured":"Llosa NJ, Cruise M, Tam A, Wicks EC, Hechenbleikner EM, Taube JM, et al. The vigorous immune microenvironment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpoints. Cancer Discov. 2015;5(1):43\u201351. https:\/\/doi.org\/10.1158\/2159-8290.cd-14-0863.","journal-title":"Cancer Discov"},{"key":"409_CR8","doi-asserted-by":"publisher","unstructured":"Le DT, Durham JN, Smith KN, Wang H, Bartlett BR, Aulakh LK ... & Diaz LA. Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade. Science. 2015; 357(6210): 409\u2013413. https:\/\/doi.org\/10.1126\/science.aaa1348.","DOI":"10.1126\/science.aaa1348"},{"key":"409_CR9","doi-asserted-by":"publisher","DOI":"10.48130\/git-0024-0005","volume":"11","author":"N Rahadiani","year":"2024","unstructured":"Rahadiani N, Effendi K, Stephanie M, Manatar AF, Krisnuhoni E. From biomarkers to outcomes: investigating DEK, p53, and Bcl-2 expression and their role in colorectal cancer stage and lymph node metastasis. Gastrointest Tumors. 2024;11:e005. https:\/\/doi.org\/10.48130\/git-0024-0005.","journal-title":"Gastrointest Tumors"},{"key":"409_CR10","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s10495-022-01780-7","volume":"28","author":"D Kaloni","year":"2023","unstructured":"Kaloni D, Diepstraten ST, Strasser A, et al. BCL-2 protein family: attractive targets for cancer therapy. Apoptosis. 2023;28:20\u201338. https:\/\/doi.org\/10.1007\/s10495-022-01780-7.","journal-title":"Apoptosis"},{"key":"409_CR11","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.semcancer.2019.07.009","volume":"55","author":"W Wang","year":"2020","unstructured":"Wang W, Kandimalla R, Huang H, Zhu L, Li Y, Gao F, et al. Molecular subtyping of colorectal cancer: Recent progress, new challenges and emerging opportunities. Semin Cancer Biol. 2020;55:37\u201352. https:\/\/doi.org\/10.1016\/j.semcancer.2019.07.009.","journal-title":"Semin Cancer Biol"},{"key":"409_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-33153-8","volume":"13","author":"Y Zhan","year":"2023","unstructured":"Zhan Y, Ni K, Liu Z, et al. Stage III deficient mismatch repair colon patients get greater benefit from earlier starting oxaliplatin-based chemotherapy regimen. Sci Rep. 2023;13:8969. https:\/\/doi.org\/10.1038\/s41598-023-33153-8.","journal-title":"Sci Rep"},{"issue":"1","key":"409_CR13","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a041004","volume":"14","author":"DR Green","year":"2022","unstructured":"Green DR. A matter of life and death. Cold Spring Harb Perspect Biol. 2022;14(1):a041004. https:\/\/doi.org\/10.1101\/cshperspect.a041004.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"409_CR14","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.actbio.2022.04.005","volume":"145","author":"B Liang","year":"2022","unstructured":"Liang B, Jiang D, Pan L, Xiong F, Feng S, Wu S, et al. Lipase-triggered drug release from BCL2 inhibitor ABT-199-loaded nanoparticles to elevate anti-leukemic activity through enhanced drug targeting on the mitochondrial membrane. Acta Biomater. 2022;145:246\u201359. https:\/\/doi.org\/10.1016\/j.actbio.2022.04.005.","journal-title":"Acta Biomater"},{"issue":"4","key":"409_CR15","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/j.1365-2559.2006.02513.x","volume":"49","author":"CR Taylor","year":"2006","unstructured":"Taylor CR, Levenson RM. Quantification of immunohistochemistry\u2014issues concerning methods, utility, and semiquantitative assessment II. Histopathology. 2006;49(4):411\u201324. https:\/\/doi.org\/10.1111\/j.1365-2559.2006.02513.x.","journal-title":"Histopathology"},{"key":"409_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.985363","volume":"12","author":"S Qian","year":"2022","unstructured":"Qian S, Wei Z, Yang W, Huang J, Yang Y, Wang J. The role of BCL-2 family proteins in regulating apoptosis and cancer therapy. Front Oncol. 2022;12:985363. https:\/\/doi.org\/10.3389\/fonc.2022.985363.","journal-title":"Front Oncol"},{"key":"409_CR17","doi-asserted-by":"publisher","unstructured":"Sun L, Zhang L, Yu J, Zhang Y, Pang X, Ma C, ... & Liu W. (2018). PD-L1 expression in renal cell carcinoma and its correlation with clinical outcomes: A retrospective analysis. Front Oncol. 2018; 8: 584. https:\/\/doi.org\/10.3389\/fonc.2018.00584.","DOI":"10.3389\/fonc.2018.00584"},{"key":"409_CR18","doi-asserted-by":"publisher","unstructured":"El-Deiry WS, Goldberg RM, Lenz HJ, Shields AF, Gibney GT, Tan AR, ... & Hochster HS. The current state of molecular testing in the treatment of patients with solid tumors, 2019. CA Cancer J Clin. 2019; 69(4): 305\u2013333. https:\/\/doi.org\/10.3322\/caac.21560.","DOI":"10.3322\/caac.21560"},{"issue":"4","key":"409_CR19","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.aogh.2016.04.002","volume":"81","author":"NA Alwan","year":"2016","unstructured":"Alwan NA. Cancer control initiatives in Iraq. Ann Glob Health. 2016;81(4):454\u201362. https:\/\/doi.org\/10.1016\/j.aogh.2016.04.002.","journal-title":"Ann Glob Health"},{"key":"409_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-018-0715-8","author":"W Tor\u00e9n","year":"2018","unstructured":"Tor\u00e9n W, Ansari D, Andersson R. Immunohistochemical investigation of prognostic biomarkers in resected colorectal liver metastases: a systematic review and meta-analysis. Cancer Cell Int. 2018. https:\/\/doi.org\/10.1186\/s12935-018-0715-8.","journal-title":"Cancer Cell Int"},{"key":"409_CR21","doi-asserted-by":"publisher","unstructured":"Yoshimura, K., Shimura, T., Ma, R., Huang, Y., Kitajima, T., Yamashita, S. ... Toiyama, Y. (2026). Andrographis exerts antitumor effects and enhances 5\u2011FU efficacy via the alteration of ferroptosis\u2011related genes in esophageal squamous cell carcinoma. Oncology Reports, 55, 99. https:\/\/doi.org\/10.3892\/or.2026.9104.","DOI":"10.3892\/or.2026.9104"},{"key":"409_CR22","doi-asserted-by":"publisher","unstructured":"Menkiti FE, Okani CO, Onyiaorah IV, et al. Immunohistochemical expression of PD-L1 in colorectal carcinoma among black patients and the clinicopathological correlates: a cross-sectional study. BMC Gastroenterol. 2025;25(1):277. Published 2025 Apr 20. https:\/\/doi.org\/10.1186\/s12876-025-03862.","DOI":"10.1186\/s12876-025-03862"},{"key":"409_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1091383","volume":"12","author":"Y Wang","year":"2023","unstructured":"Wang Y, Li M, Wang G, Wu H. Role of B7 family members in glioma: promising new targets for tumor immunotherapy. Front Oncol. 2023;12:1091383. https:\/\/doi.org\/10.3389\/fonc.2022.1091383.","journal-title":"Front Oncol"},{"issue":"11","key":"409_CR24","doi-asserted-by":"publisher","first-page":"9647","DOI":"10.3390\/curroncol30110699","volume":"30","author":"J Liu","year":"2023","unstructured":"Liu J, Li J, Luo F, Wu S, Li B, Liu K. The predictive value of CD3+\/CD8+ lymphocyte infiltration and PD-L1 expression in colorectal cancer. Curr Oncol. 2023;30(11):9647\u201359. https:\/\/doi.org\/10.3390\/curroncol30110699.","journal-title":"Curr Oncol"},{"issue":"10","key":"409_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics14101007","volume":"14","author":"M Fran\u010dina","year":"2024","unstructured":"Fran\u010dina M, Miku\u0161 M, Mami\u0107 M, Jovanovi\u0107 T, \u0106ori\u0107 M, Lovri\u0107 B, et al. Evaluation of PD-L1 expression in colorectal carcinomas by comparing scoring methods and their significance in relation to clinicopathologic parameters. Diagnostics (Basel, Switzerland). 2024;14(10):1007. https:\/\/doi.org\/10.3390\/diagnostics14101007.","journal-title":"Diagnostics (Basel, Switzerland)"}],"container-title":["Journal of the Egyptian National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43046-026-00409-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43046-026-00409-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43046-026-00409-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T08:10:37Z","timestamp":1788509437000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s43046-026-00409-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,4]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["409"],"URL":"https:\/\/doi.org\/10.1186\/s43046-026-00409-z","relation":{},"ISSN":["2589-0409"],"issn-type":[{"value":"2589-0409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,4]]},"assertion":[{"value":"7 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Committee of Medical Ethics of University of Anbar has approved this research with the approval number 15, in March 15, 2022) according to the Declaration of Helsinki. All of the study participants who were patients or their parents provided written informed consent.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"67"}}